Results 121 to 130 of about 21,275,692 (207)

Identification of JAML as an Immune-Associated Prognostic Marker in Non-Small Cell Lung Cancer. [PDF]

Lung Cancer (Auckl)
Tian Q, Zhang F, Han C.
europepmc   +1 more source

CNTN5 Promotes Invasion and Metastasis in Non-Small Cell Lung Cancer by Regulating YAP1 Nuclear Translocation. [PDF]

J Gene Med
Wang J, Wang M, Yin Y, Zeng A, Chen K, Xu Z, Dai J.   +6 more
europepmc   +1 more source

Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non-Small Cell Lung Cancer. [PDF]

Cancer Res Commun
Sen U, Natour D, Chakraborty S, Gobbini E, Fan CW, Koelbel C, Elliott A, Vanderwalde AM, Borghaei H, Halmos B, Demircioglu D, Hasson D, Gandhi N, Sen T.   +13 more
europepmc   +1 more source

Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset. [PDF]

Clin Pharmacol Ther
Grit GF, van Dartel M, Rodwell L, van der Woude H, Boersma C, Mol PGM, Hilarius D.   +6 more
europepmc   +1 more source

Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

Defining the tumor microenvironment of non-small cell lung cancer. [PDF]

Immunol Cell Biol
Embaye KS, Blick T, Naei VY, O'Byrne K, Hughes BGM, Kulasinghe A.   +5 more
europepmc   +1 more source

Afatinib in Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology, 2015
openaire   +2 more sources

Engineering the Future of ADCs in Non-Small Cell Lung Cancer. [PDF]

Oncol Res
Kim MR, Lau J, Maffezzoli M, Banna GL.
europepmc   +1 more source

Unveiling BRAF Mutations in Non-small Cell Lung Cancer: State of the Art and Future Perspectives. [PDF]

Lung
Colombino M, Paliogiannis P, Palomba G, Pisano M, Casula M, Fois AG, Zinellu A, Palmieri G.   +7 more
europepmc   +1 more source

The Role of KRAS in Non-Small Cell Lung Cancer: From Molecular Background to Precision Medicine. [PDF]

Int J Mol Sci
Gaździcka J, Gołąbek K.
europepmc   +1 more source